touchCARDIO publishes two peer-reviewed, free-to-access journals, that aim to provide insightful and topical articles relevant to the day-to-day practice of busy physicians. View our latest and archive content below.
More information about our journals along with how to submit your work can be found here.
Ratio of Serum Aspartate to Alanine Aminotransferase as a Marker of Isolated Coronary Artery Ectasia and its Severity
Heart International. 2020;14(1):43–8 DOI: https://doi.org/10.17925/HI.2020.14.1.43
The exact aetiology of coronary artery ectasia (CAE) has yet to be fully elucidated; however, some underlying aetiologies such as atherosclerosis and microvascular abnormalities in coronary arteries have been proposed.1,2 Over the past few years, several inflammatory markers have been introduced as indicators of CAE and its severity. There is an association between the development of […]
Cardiovascular Effects of COVID-19 – What Do We Know and Where Should We Go?
Heart International. 2020;14(1):16–9 DOI: https://doi.org/10.17925/HI.2020.14.1.16
The current pandemic of coronavirus disease 2019 (COVID-19) is an unprecedented public health emergency, with worldwide health, social and economic implications. In contrast to other modern epidemics, little prior knowledge of the pathogen existed. Whilst this initially hampered both patient management and the public health response, we have observed a remarkable worldwide attempt to provide […]
Foreword – Heart International. 2020;14(1):8
Heart International. 2020;14(1):8
Dear colleagues, welcome to the summer issue of Heart International. We hope this reaches you well and that your personal and professional lives have not been affected adversely by the coronavirus pandemic. As is fitting for the current circumstances, we include an editorial by Prof. Perera’s group on the effects of COVID-19 on cardiovascular health. The […]
Is There Still a Place for Revascularisation in the Management of Stable Coronary Artery Disease Following the ISCHEMIA Trial?
Heart International. 2020;14(1):13-5 DOI: https://doi.org/10.17925/HI.2020.14.1.13
Optimal medical therapy (OMT) is the cornerstone of management in patients with coronary atheroma, given the substantial evidence that it can delay disease progression and damp down both chronic and acute vascular inflammation, thereby leading to a reduction in cardiovascular events and mortality.1,2 In this context, revascularisation, with either percutaneous coronary intervention (PCI) or coronary […]
The Coronary Sinus Reducer – Clinical Evidence and New Perspectives On An Emerging Tool in the Treatment of Refractory Angina
Heart International. 2020;14(1):29-33 DOI: https://doi.org/10.17925/HI.2020.14.1.29
Refractory angina pectoris is a chronic disabling condition affecting an increasing number of patients (10–15%) with severe ischaemic heart disease.1 It is generally defined as the presence of debilitating angina due to severe and/or diffuse coronary artery disease (CAD), despite optimal medical therapy and with no option for further percutaneous or surgical revascularisation procedures. As […]
Persistent Myocardial Ischaemia due to Anaemia in a Patient with Coeliac Disease – A Case Report
Heart International. 2020;14(1):49-52 DOI: https://doi.org/10.17925/HI.2020.14.1.49
Coeliac disease (CD) is a systemic disease of inappropriate immune response to gluten, which affects up to 1% of the population in the Western world.1 Gluten proteins are found in dietary products containing wheat, rye, barley and related grains. In patients who carry the human leukocyte antigen (HLA)-DQ2 and HLA-DQ8 alleles of the major histocompatibility […]
A Rare Case of Cor Triatriatum Sinister in Adulthood with Atypical Manifestation
Heart International. 2020;14(1):53-5 DOI: https://doi.org/10.17925/HI.2020.14.1.53
First described in 1868 by WS Church, cor triatriatum sinister (CTS) is one of the rarest congenital heart diseases in the world, with an estimated incidence of 0.1%.1,2 It is characterised by the presence of a fibrous membrane that divides the left atrium into two different regions: a proximal chamber with the pulmonary veins and […]
Clopidogrel-induced Pill Oesophagitis
Heart International. 2020;14(1):56-8 DOI: https://doi.org/10.17925/HI.2020.14.1.56
Antiplatelet agents are routinely given to prevent thrombosis of coronary stents.1 When antiplatelet drugs are not given before percutaneous coronary intervention (PCI), they may be given on the table during PCI.1 Ingestion of pills while supine on the catheterisation table often causes mild dysphagia and discomfort but, rarely, it can cause a more serious event. […]
Patent Foramen Ovale Closure—Addressing the Unmet Need for Reducing the Risk of Ischemic Stroke
US Neurology. 2020;16(1):54–60
Globally, a high proportion (around 25%) of transient ischemic attacks (TIAs) and ischemic strokes are cryptogenic.1,2 The Trial of ORG 10172 in Acute Stroke Treatment (TOAST) classification defines a cryptogenic stroke as a brain infarction that is not caused by definite cardioembolism, large artery atherosclerosis, or small artery disease, despite extensive investigations.3 The “ASCOD” classification defines strokes […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!